{"id":10912,"date":"2026-03-04T23:02:22","date_gmt":"2026-03-04T23:02:22","guid":{"rendered":"https:\/\/mailitics.com\/index.php\/2026\/03\/04\/biotech-news-fda-warns-telehealth-about-glp-1-compounding\/"},"modified":"2026-03-04T23:02:22","modified_gmt":"2026-03-04T23:02:22","slug":"biotech-news-fda-warns-telehealth-about-glp-1-compounding","status":"publish","type":"post","link":"https:\/\/mailitics.com\/index.php\/2026\/03\/04\/biotech-news-fda-warns-telehealth-about-glp-1-compounding\/","title":{"rendered":"STAT+: FDA warns more telehealth firms about compounded GLP-1s"},"content":{"rendered":"<p>    STAT+: FDA warns more telehealth firms about compounded GLP-1s<br \/>\n \t<BR><br \/>\n<BR><\/BR><br \/>\n    <!-- no image --><br \/>\n \t<BR><br \/>\n<BR><\/BR><\/p>\n<div>\n<p><em>Want to stay on top of the science and politics driving biotech today?\u00a0<a href=\"https:\/\/www.statnews.com\/signup\/readout\/\">Sign up<\/a>\u00a0to get our biotech newsletter in your inbox.<\/em><\/p>\n<p>Good morning. Moderna is avoiding what would have been a high-profile trial, but will still have to pay up. That and more news below. Let\u2019s get to it.<\/p>\n<h2 class=\"wp-block-heading\" id=\"h-moderna-to-pay-major-settlement-in-roivant-patent-case\">Moderna to pay major settlement in Roivant patent case<\/h2>\n<p>Moderna has agreed to pay Roivant up to $2.25 billion to settle claims that it infringed on Roivant\u2019s patents with\u00a0its Covid-19 shot.<\/p>\n<p><a href=\"https:\/\/www.statnews.com\/2026\/03\/04\/biotech-news-fda-warns-telehealth-about-glp-1-compounding\/?utm_campaign=rss\">Continue to STAT+ to read the full story\u2026<\/a><\/p>\n<\/div>\n<p> \t<BR><br \/>\n <BR><\/BR><br \/>\n    Elaine Chen<br \/>\n \t<BR><br \/>\n<BR><\/BR><br \/>\n<a href=\"https:\/\/www.statnews.com\/2026\/03\/04\/biotech-news-fda-warns-telehealth-about-glp-1-compounding\/?utm_campaign=rss\">Go to statnews<\/a><br \/>\n \t<BR><br \/>\n <BR><\/BR><\/p>\n","protected":false},"excerpt":{"rendered":"<p>STAT+: FDA warns more telehealth firms about compounded GLP-1s Want to stay on top of the science and politics driving biotech today?\u00a0Sign up\u00a0to get our biotech newsletter in your inbox. Good morning. Moderna is avoiding what would have been a high-profile trial, but will still have to pay up. That and more news below. Let\u2019s [&hellip;]<\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[2194,2154,58,2208,2209,2176,858,2207],"tags":[2150],"class_list":["post-10912","post","type-post","status-publish","format-standard","hentry","category-biotech","category-biotechnology","category-business","category-drug-development","category-drug-prices","category-pharma","category-research","category-the-readout","tag-statnews"],"_links":{"self":[{"href":"https:\/\/mailitics.com\/index.php\/wp-json\/wp\/v2\/posts\/10912"}],"collection":[{"href":"https:\/\/mailitics.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/mailitics.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/mailitics.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/mailitics.com\/index.php\/wp-json\/wp\/v2\/comments?post=10912"}],"version-history":[{"count":0,"href":"https:\/\/mailitics.com\/index.php\/wp-json\/wp\/v2\/posts\/10912\/revisions"}],"wp:attachment":[{"href":"https:\/\/mailitics.com\/index.php\/wp-json\/wp\/v2\/media?parent=10912"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/mailitics.com\/index.php\/wp-json\/wp\/v2\/categories?post=10912"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/mailitics.com\/index.php\/wp-json\/wp\/v2\/tags?post=10912"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}